We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$55.7B
$55.7B $17.44 1.16%
HLN icon
2
Haleon
HLN
$43.8B
$43.8B $9.94 1.64%
TEVA icon
3
Teva Pharmaceuticals
TEVA
$36.2B
$36.2B $31.08 0.88%
ZTS icon
4
Zoetis
ZTS
$32.2B
$32.2B $76.92 2.08%
UTHR icon
5
United Therapeutics
UTHR
$26.3B
$26.3B $527.94 0.1%
VTRS icon
6
Viatris
VTRS
$20.5B
$20.5B $17.64 2.32%
NBIX icon
7
Neurocrine Biosciences
NBIX
$17.7B
$17.7B $176.41 0.36%
ELAN icon
8
Elanco Animal Health
ELAN
$12.7B
$12.7B $25.41 2.01%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$9.8B
$9.8B $11.77 0.17%
ALKS icon
10
Alkermes
ALKS
$8.79B
$8.79B $52.73 0.3%
LQDA icon
11
Liquidia Corp
LQDA
$7.51B
$7.51B $84.42 2.09%
LNTH icon
12
Lantheus
LNTH
$7.03B
$7.03B $108.03 3.06%
HIMS icon
13
Hims & Hers Health
HIMS
$7B
$7B $30.24 7.65%
AMRX icon
14
Amneal Pharmaceuticals
AMRX
$5.78B
$5.78B $18.09 0.95%
KNSA icon
15
Kiniksa Pharmaceuticals
KNSA
$4.89B
$4.89B $63.53 1.1%
INDV icon
16
Indivior Pharmaceuticals
INDV
$4.73B
$4.73B $40.03 1.23%
RGC icon
17
Regencell Bioscience
RGC
$2.88B
$2.88B $5.83 1.92%
SUPN icon
18
Supernus Pharmaceuticals
SUPN
$2.73B
$2.73B $46.98 1.69%
BCRX icon
19
BioCryst Pharmaceuticals
BCRX
$2.43B
$2.43B $9.58 2.57%
PBH icon
20
Prestige Consumer Healthcare
PBH
$2.39B
$2.39B $50.40 1.49%
AMLX icon
21
Amylyx Pharmaceuticals
AMLX
$2.17B
$2.17B $19.49 5.87%
HCM icon
22
HUTCHMED
HCM
$1.91B
$1.91B $11.12 1%
ANIP icon
23
ANI Pharmaceuticals
ANIP
$1.78B
$1.78B $78.37 0.93%
BHC icon
24
Bausch Health
BHC
$1.67B
$1.67B $4.48 1.13%
TRLV
25
Trulieve Cannabis Corp
TRLV
$1.6B
$1.6B $8.33 0.36%
1
2 3 4

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 83 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $341B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $55.7B, Haleon (HLN) at $43.8B and Teva Pharmaceuticals (TEVA) at $36.2B.

Among institutional investors, Amneal Pharmaceuticals (AMRX) drew the most net new fund positions in Q1 2026: 80 funds opened new positions, taking total fund holders up 39 (14%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.